ホーム › 多発性骨髄腫 › ニューヨーク › New Rochelle
New Rochelle、NYにおける多発性骨髄腫の臨床試験
New Rochelleとその周辺地域（約30マイル以内）の拠点で、多発性骨髄腫に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
被験者募集中第2相
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
被験者募集中
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
被験者募集中第2相
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5マイル先
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
被験者募集中第3相
- MSK Westchester, Harrison · 5マイル先
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
被験者募集中第3相
- MSK Westchester, Harrison · 5マイル先
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
被験者募集中第3相
- North Shore University Hospital, Manhasset · 9マイル先
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
被験者募集中第1相
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5マイル先
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
被験者募集中観察研究
- Memorial Sloan Kettering Westchester (Consent only), Harrison · 5マイル先
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
被験者募集中第1/2相
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5マイル先
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
被験者募集中第2相
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5マイル先
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
被験者募集中第2相
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5マイル先
A Dietary Study for People With Multiple Myeloma
被験者募集中
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5マイル先
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
被験者募集中第2相
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5マイル先
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Westchester, Harrison · 5マイル先
他の都市における多発性骨髄腫の試験
- New York City, NY60件の研究
- Boston, MA42件の研究
- Atlanta, GA42件の研究
- Houston, TX38件の研究
- Durham, NC37件の研究
- Nashville, TN32件の研究
- Denver, CO27件の研究
- Rochester, MN24件の研究
- St. Louis, MO24件の研究
- Columbus, OH24件の研究
- Baldwin Park, CA23件の研究
- Edison, NJ22件の研究
New Rochelleにおける他の研究
- 乳がん38件の研究
- 非小細胞肺癌18件の研究
- 前立腺がん16件の研究
- 急性骨髄性白血病13件の研究
- 膀胱癌11件の研究
- 肺がん11件の研究
- 子宮内膜がん11件の研究
- 転移性癌10件の研究
- がん（全種類）10件の研究
- 卵巣がん9件の研究
- 心血管疾患8件の研究
- 膵臓がん8件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。